Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster
- 30 July 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 398 (3), 532-536
- https://doi.org/10.1016/j.bbrc.2010.06.113
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council (81272)
This publication has 38 references indexed in Scilit:
- Angiotensin-Converting Enzyme - New Insights into Structure, Biological Significance and Prospects for Domain-Selective InhibitorsCurrent Enzyme Inhibition, 2009
- Ace revisited: A new target for structure-based drug designNature Reviews Drug Discovery, 2003
- Just the Beginning: Novel Functions for Angiotensin-Converting EnzymesCurrent Biology, 2002
- Drugs targeting the renin–angiotensin–aldosterone systemNature Reviews Drug Discovery, 2002
- The angiotensin–converting enzyme gene family: genomics and pharmacologyTrends in Pharmacological Sciences, 2002
- N-Domain–Specific Substrate and C-Domain Inhibitors of Angiotensin-Converting EnzymeHypertension, 1998
- Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzymeBiochemical Pharmacology, 1997
- The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting EnzymeJournal of Biological Chemistry, 1995
- Angiotensin-converting enzyme: new concepts concerning its biological roleBiochemistry, 1989
- Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.Proceedings of the National Academy of Sciences, 1988